| Literature DB >> 35658586 |
Salwa Bakr1,2, Areej AlFattani3, Randa Al-Nounou4, Nasir Bakshi4, Haitham Khogeer4, Maha Alharbi4, Nasser Almousa4, Waleed Alomaim4, Amelita Aguilos4, May Almashary2, Tarek Owaidah4,5.
Abstract
BACKGROUND: Laboratory hematological tests are widely used in clinical practice to assess health and disease conditions. Reference ranges provided by laboratory reports are considered the most authoritative medical tools to assist in the decision-making phase. International standards institutes recommend that reference ranges be established for each region.Entities:
Mesh:
Year: 2022 PMID: 35658586 PMCID: PMC9167458 DOI: 10.5144/0256-4947.2022.191
Source DB: PubMed Journal: Ann Saudi Med ISSN: 0256-4947 Impact factor: 1.707
Age distribution of the estimated sample population (n=637).
| Age group (years) | Males | Females |
|---|---|---|
| Total | 478 (75) | 159 (25) |
| 15–19 | 42 (9) | 35 (22) |
| 20–24 | 65 (14) | 48 (30) |
| 25–29 | 76 (16) | 20 (13) |
| 30–34 | 75 (16) | 18 (11) |
| 35–39 | 81 (17) | 18 (11) |
| 40–44 | 64 (13) | 7 (4) |
| 45–49 | 41 (9) | 6 (4) |
| 50–54 | 15 (3) | 3 (2) |
| 55–59 | 9 (2) | 4 (2) |
| 60–64 | 10 (2) | 1 (1) |
Data are n (%).
Hematological reference interval of Saudi adults in comparison with Western values.
| Parameter | Current study values with reference range | Western values with range |
|---|---|---|
| Red blood indices | ||
| Red blood cell count (× 1012/L) | ||
| Males (× 1012/L) | 5.4 (0.4); S.2–5.7 | 5.0 (.5)[ |
| Female (× 1012/L) | 4.8 (0.4); 4.5–5.0 | 4.3 (0.5)[ |
| Hemoglobin | ||
| Male (g/dL) | 154.0 (12.0); 129–179 | 150 (20)[ |
| Female (g/dL) | 133.9 (10.1); 114–154 | 135 (15)[ |
| Hematocrit | ||
| Male (%) | 0.4 (0.0); 0.4–.5 | 0.4 (0.0)[ |
| Female (%) | 0.5 (0.0); 0.4–0.5 | 0.4 (0.0)[ |
| Mean corpuscular volume (fL) | 86.9 (4.3); 77.4–94.6 | 92 (9)[ |
| Mean corpuscular hemoglobin (pg) | 28.4 (1.7); 24.7–32.7 | 29.5 (2.5)[ |
| Mean corpuscular hemoglobin concentration (g/dL) | 324.8 (9.7); 304.8–344.0 | 330 (15)[ |
| Red cell distribution w/idth-SD (fL) | 41.4 (2.6); 36.5–46.5 | 42.5 (3.5)[ |
| Red cell distribution width-CV (%) | 13.0 (0.8); 11.8–14.9 | 12.8 (1.2)[ |
| Reticulocyte (× 109/L) (%) | 69.6 (22.0); 53.7–84.2 1.4 (0.4); 1.1–1.6 | 50–100[ |
| White blood indices (× 109/L) | ||
| Total WBC (× 109/L) | 6.7 (1.8); 3.6–10.6 | 4.0–10.0[ |
| Neutrophils (× 109/L) | 3.5 (1.4); 1.0–6.5 | 2.0–7.0[ |
| Neutrophils (%) | 51.1 (10.7); 44.6–58.6 | 40–80[ |
| Lymphocytes (× 109/L) | 2.5 (0.7); 1.3–3.8 | 1.0–3.0[ |
| Lymphocyte (%) | 37.7 (8.8); 30.9–42.8 | 20–40[ |
| Monocytes (× 109/L) | 0.5 (0.2); 0.2–0.9 | 0.–1.0[ |
| Monocytes (%) | 7.8 (1.9); 4.6–12.3 | 2–10[ |
| Eosinophil (× 109/L) | 0.1 (0.1); 0.0–0.4 | 0.0–0.5[ |
| Eosinophil (%) | 2.4 (1.7); 0.2–7.0 | 1–6[ |
| Basophils (× 109/L) | 0.0 (0.0); 0.0–0.1 | 0.02–0.1[ |
| Basophils (%) | 0.6 (0.3); 0.2–1.3 | <1–2[ |
| Platelet indices | ||
| Platelet count (× 109/L) | 264.0 (60.5); 219–303 | 280 (130); 150–410[ |
| Platelet distribution width (fL) | 13.0 (2.0); 9.6–17.3 | |
| Mean platelet volume (fL) | 10.8 (0.9); 9.2–12.7 |
Mean (standard deviation) for normally distributed (red blood cell indices) and median (interquartile range) for non-normally distributed data are presented with he reference range.
Predominantly from Europe and North America according to Dacie and Lewis, Practical Hematology, 12th edition, and
William Manual 5f Hematology. 9th edition, respectively.
RDW-CV: Red Cell Distribution width - Coefficient of Variation RDW-SD: Red Cell Distribution width - Standard Deviation
Hemostatic profile reference interval of Saudi adults in comparison with Western values.
| Parameter | Current study values with reference range | Western values with range |
|---|---|---|
| Hemostatic profile | ||
| Prothrombin time (sec) | 13.8 (0.6); 12.6–15.0 | 10–12[ |
| International normalized ratio | 1.0 (0.0); 0.9–1.1 | 0.8–1.2[ |
| Partial thromboplastin time (sec) | 35.6 (2.7); 30.7–41.5 | 26–40[ |
| APTT ratio | 1.12 (0.9); 0.9–1.3 | 1.8–3.6[ |
| Fibrinogen conc. (g/L) | 3.3 (0.6); 2.1–4.6 | 1.8–3.6[ |
| D-dimer (ug/mL) | 0.3 (0.0); 0.2–0.4 | 0.40 ng/mL[ |
| Reptilase time (sec) | 18.3 (0.8); 17.6–18.9 | |
| Thrombin time (sec) | 16.5 (0.8); 15.8–17.0 | 15–19[ |
| Antithrombin (%) | 99.3 (8.4); 93.0–105.0 | 75–125[ |
| Factor II (%) | 95.7 (14.9); 86.0–106.0 | 50–150[ |
| Factor V (%) | 80.1 (23.7); 63.1–97.0 | 50–150[ |
| Factor VII (%) | 88.0 (23.9); 71.0–104.0 | 50–150[ |
| Factor VIII (%) | 89.3 (36.0); 31.7–171.7 | 50–200[ |
| Factor IX (%) | 114.3 (29.1); 95.0–135.0 | 50–150[ |
| Factor X (%) | 86.5 (16.1); 75.0–98.0 | 50–150[ |
| Factor XI (%) | 102.8 (18.9); 64.2–146.0 | 50–150[ |
| Factor XII (%) | 110.6 (34.7); 55.0–188.0 | 50–150[ |
| Factor XIII (%) | 124.7 (34.1); 68.0–200.0 | 70–130[ |
| Von Willebrand Factor (%) | 84.5 (22.6); 73.0–97.0 | 50–200[ |
| Protein S (%) | 93.5 (26.7); 74.2–114.0 | 60–135[ |
| Protein C (%) | 84.8 (21.8); 69.9–98.6 | 70–140[ |
| Plasminogen conc. (%) | 97.9 (14.2); 86.1–108.9 | 75–160[ |
Mean (standard deviation) for reptilase and remaining parameters) an median (interquartile range) for promthrombin to D-dimer with reference range.
Predominantly from Europe and North America according to Dacie and Lewis, Practical Hematology, 12th edition, and
William Manual of Hematology, 9th edition
Serum hematinics profile reference interval of Saudi adults in comparison with Western values.
| Parameter | Current study values with reference range | Western values with range |
|---|---|---|
| Serum hematinic | ||
| Iron (umol/L) | 15.2 (6.0); 10.6–19.0 | 10–30[ |
| Ferritin | ||
| Men (ug/L) | 84.8 (61.5); 9.2–232.6 | 15–300[ |
| Women (ug/L) | 36.1 (86.1); 8.2–130.0 | 15–200[ |
| Vitamin B12 (pmol/L) | 240.1 (86.1); 100.5–428.0 | 180–640[ |
| Folate (nmol/L) | 22.0 (10.9); 4.6–45.4 | 6.8–45[ |
Mean (standard deviation) for iron and median (interquartile range) for remaining parameters and reference range. Predominantly from Europe and North America according to Dade and Lewis.
Practical Hematology. 12th edition, and
William Manual of Hematology, 9th edition
Full blood count normal reference values in male and female Saudi adults.
| Parameter | Mean (SD) with reference range | Lower limit (90% Cl) | Upper limit (90% Cl) | Minimum | Maximum |
|---|---|---|---|---|---|
| Red blood cell counts (×1012/L) | |||||
| Male | 5.4 (0.4)[ | 4.4–5.9 | 5.0–6.4 | 4.0 | 6.7 |
| Female | 4.8 (0.4); 4.5–5.0 | 3.9–5.1 | 4.4–5.6 | 4.0 | 6.0 |
| Hemoglobin (g/dL) | |||||
| Male | 15.4 (1.2)[ | 10.9–14.9 | 15.9–19.9 | 11.1 | 19.1 |
| Female | 13.4 (1.0); 11.4–15.4 | 9.7–13.0 | 13.7–17.0 | 10.8 | 16.4 |
| Hematocrit (%) | |||||
| Male | 0.5 (0.0)[ | 0.4–0.5 | 0.5–0.6 | 0.4 | 0.6 |
| Female | 0.4 (0.0); 0.4–0.5 | 0.3–0.4 | 0.4–0.5 | 0.4 | 0.5 |
| Mean corpuscular volume (fL) | |||||
| Male | 86.6 (4.3); 77.6–95.0 | 70.6–84.6 | 87.9–101.9 | 74.7 | 98.5 |
| Female | 87.1 (4.3); 76.6–94.2 | 69.6–83.7 | 87.4–101.4 | 74.6 | 96.1 |
| Mean corpuscular hemoglobin (pg) | |||||
| Male | 28.5 (1.8)[ | 21.6–27.5 | 28.8–34.8 | 23.5 | 32.7 |
| Female | 28.2 (1.5); 24.8–31.1 | 22.4–27.5 | 28.4–33.4 | 24.0 | 32.3 |
| Mean corpuscular hemoglobin concentration (g/dL) | |||||
| Male | 32.7 (10.1)[ | 28.7–32.0 | 32.8–36.1 | 29.9 | 35.3 |
| Female | 32.2 (8.2); 30.5–33.9 | 29.1–31.8 | 32.6–35.3 | 30.3 | 34.6 |
| Red cell distribution width-SD (fL) | |||||
| Male | 41.1 (2.7)[ | 31.6–40.5 | 42.3–51.2 | 34.7 | 48.6 |
| Female | 41.7 (2.4); 37.4–46.3 | 33.5–41.3 | 42.4–50.2 | 34.2 | 47.8 |
| Red cell distribution width-CV (%) | |||||
| Male | 13.0 (0.8); 11.7–14.8 | 10.4–13.0 | 13.5–16.1 | 10.9 | 15.3 |
| Female | 13.1 (0.8); 11.8–15.1 | 10.6–13.0 | 13.9–16.3 | 11.8 | 15.3 |
| Reticulocyte count (× 109/L) | |||||
| Male | 77.0 (16.3); 65.0–84.6 | 38.3–91.8 | 57.9–111.3 | 45.0 | 116.3 |
| Female | 66.9 (23.5); 51.6–85.1 | 13.1–90.2 | 46.6–123.7 | 30.2 | 116.3 |
| Reticulocyte (%) | |||||
| Male | 1.4 (0.3); 1.2–1.5 | 0.7–6.5 | 1.1–2.0 | 0.8 | 2.0 |
| Female | 1.3 (0.4); 1.1–1.6 | 0.4–1.8 | 1.0–2.3 | 0.6 | 2.1 |
| Normoblast (× 109/L) | |||||
| Male | 0 | 0 | 0 | ||
| Female | 0 | 0 | 0 | ||
| White blood cells (× 109/L) | |||||
| Male | 6.5 (1.7)[ | 0.8–6.5 | 7.7–13.5 | 2.4 | 11.6 |
| Female | 7.0 (1.8); 3.5–10.6 | 0.4–6.5 | 7.6–13.6 | 2.8 | 11.2 |
| Neutrophils # (× 109/L) | |||||
| Male | 3.2 (1.3)[ | 0.01–3.21 | 4.3–8.4 | 0.6 | 6.7 |
| Female | 3.8 (1.5); 1.0–6.6 | 0.01–3.47 | 4.1–9.0 | 0.8 | 7.2 |
| Neutrophils (%) | |||||
| Male | 48.9 (9.7)[ | 27.3–59.1 | 39.5–71.3 | 23.4 | 70.1 |
| Female | 53.0 (11.1); 46.4–61.2 | 28.2–64.6 | 43.0–79.4 | 24.3 | 73.4 |
| Lymphocytes (×109/L) | |||||
| Male | 2.4 (0.6); 1.3–3.9 | 0.2–2.4 | 2.8–4.9 | 0.7 | 4.1 |
| Female | 2.5 (0.7); 1.3–3.7 | 0.2–2.4 | 2.6–4.8 | 1.2 | 3.8 |
| Lymphocytes (%) | |||||
| Male | 38.5 (8.4)[ | 18.5–46.1 | 30.6–58.3 | 20.9 | 61.9 |
| Female | 36.4 (9.0); 29.7–41.7 | 14.8–45.5 | 26.8–56.5 | 16.7 | 57.0 |
| Monocytes (× 109/L) | |||||
| Male | 0.5 (0.1)[ | 0.01–0.49 | 0.6–1.1 | 0.2 | 0.9 |
| Female | 0.5 (0.2); 0.3–0.9 | 0.01–0.53 | 0.6–1.1 | 0.3 | 0.9 |
| Monocytes (%) | |||||
| Male | 8.3 (1.8)[ | 2.1–7.9 | 9.5–15.3 | 3.9 | 12.8 |
| Female | 7.3 (1.9); 4.4–12.3 | 1.3–7.5 | 9.2–15.4 | 4.3 | 12.9 |
| Eosinophils # (× 109/L) | |||||
| Male | 0.2 (0.1)[ | 0.01–0.21 | 0.2–0.6 | 0.0 | 0.5 |
| Female | 01 (0.0); 0.0–0.4 | 0.01–0.16 | 0.2–0.5 | 0.0 | 0.4 |
| Eosinophils (%) | |||||
| Male | 2.9 (1.8)[ | 0.01–3.28 | 4.2–10.0 | 0.0 | 7.7 |
| Female | 1.9 (1.5); 0.0–7.0 | 0.01–2.61 | 4.4–9.5 | 0.0 | 7.7 |
| Basophils (× 109/L) | |||||
| Male | 0.0 (0.0)[ | 0.01–0.03 | 0.0–0.1 | 0.0 | 0.1 |
| Female | 0.0 (0.0); 0.0–0.1 | 0.01–0.03 | 0.0–0.1 | 0.0 | 0.1 |
| Basophils (%) | |||||
| Male | 0.7 (0.3)[ | 0.01–0.68 | 0.8–1.8 | 0.0 | 1.3 |
| Female | 0.5 (0.3); 0.1–1.1 | 0.01–0.53 | 0.7–1.5 | 0.1 | 1.3 |
| Platelet count (× 109/L) | |||||
| Male | 250.1 (55.8)[ | 121.5–304.5 | 194.5–377.5 | 115.0 | 410.0 |
| Female | 280.9 (61.9); 229.2–327.2 | 127.8–330.7 | 225.8–428.7 | 120.0 | 417.0 |
| Platelet distribution width (fL) | |||||
| Male | 13.1 (2.0); 9.7–17.3 | 6.4–13.0 | 14.0–20.6 | 8.6 | 18.5 |
| Female | 12.9 (2.0); 9.5–17.5 | 6.3–12.8 | 14.3–20.7 | 9.1 | 17.9 |
| Mean platelet volume (fL) | |||||
| Male | 10.8 (0.9); 9.–12.7 | 7.7–10.7 | 11.2–14.2 | 8.5 | 13.2 |
| Female | 10.9 (0.9) 9.2–12.8 | 7.7–10.7 | 11.3–14.2 | 8.9 | 13.1 |
Significant difference in values between males and females (P<.001) within age groups studied.
Significant difference in values between males and females (P<.05) t-test or Mann-whitney were appropriate).
Hemostatic normal reference values in male and female Saudi adults.
| Parameter | Mean (SD) with reference range | Lower limit (90% Cl) | Upper limit (90% Cl) | Minimum | Maximum |
|---|---|---|---|---|---|
| Prothrombin time (sec) | |||||
| Male | 13.7 (0.6)[ | 11.4–13.6 | 14.0–16.1 | 12.0 | 15.5 |
| Female | 13.9 (0.6); 12.8–15.0 | 11.9–13.8 | 14.1–15.9 | 12.2 | 15.1 |
| International normalized ratio | |||||
| Male | 1.0 (0.1)[ | 0.8–1.0 | 1.0–1.2 | 0.9 | 1.2 |
| Female | 1.0 (0.0); 0.9–1.2 | 0.8–1.0 | 1.1–1.2 | 0.9 | 1.2 |
| Active partial thromboplastin time (sec) | |||||
| Male | 35.3 (2.8)[ | 25.4–34.6 | 36.8–46.0 | 28.5 | 43.1 |
| Female | 36.1 (2.6); 31.8–41.5 | 27.6–36.1 | 37.2–45.7 | 29.7 | 43.1 |
| APPT ratio | |||||
| Male | 1.1 (1.0); 0.9–1.3 | 0.6 | 14.2 | ||
| Female | 1.1 (0.9); 0.9–1.3 | 0.8 | 11.0 | ||
| Fibrinogen conc. (g/L) | |||||
| Male | 3.1 (0.6)[ | 1.1–3.1 | 3.5–5.5 | 1.4 | 4.9 |
| Female | 3.4 (0.6)[ | 1.2–3.2 | 3.9–5.9 | 1.8 | 4.9 |
| D-dimer (ug/mL) | |||||
| Male | 0.3 (0.0)[ | 0.1–0.3 | 0.3–0.5 | 0.2 | 0.4 |
| Female | 0.3 (0.0); 0.2–0.4 | 0.1–0.3 | 0.3–0.5 | 0.2 | 0.4 |
| Reptilase time (sec) | |||||
| Male | 18.4 (0.8); 17.7–18.9 | 16.4–19.0 | 17.6–20.2 | 16.8 | 20.9 |
| Female | 18.1 (0.8); 17.6–18.7 | 16.3–18.9 | 17.4–20.0 | 16.5 | 19.5 |
| Thrombin time (sec) | |||||
| Male | 16.5 (0.8); 15.9–17.1 | 14.6–17.2 | 15.7–18.4 | 14.5 | 18.8 |
| Female | 16.3 (0.9); 15.8–16.8 | 14.3–17.3 | 15.3–18.3 | 14.9 | 18.9 |
| Antithrombin (%) | |||||
| Male | 98.0 (8.5)[ | 78.1–105.9 | 90.1–117.9 | 78.0 | 119.0 |
| Female | 100.9 (8.0); 95.0–107.0 | 81.8–108.2 | 93.8–120.2 | 77.0 | 120.0 |
| Factor II (%) | |||||
| Male | 94.1 (15.8); 83.6–105.0 | 57.7–109.5 | 79.1–130.9 | 59.0 | 132.0 |
| Female | 96.0 (14.6); 87.2–106.7 | 63.3–111.2 | 82.8–130.7 | 56.0 | 132.0 |
| Factor V (%) | |||||
| Male | 88.2 (24.9)[ | 30.1–111.9 | 65.5–147.5 | 31.0 | 148.0 |
| Female | 77.0 (22.5); 60.0–92.0 | 23.1–96.9 | 55.1–128.9 | 27.0 | 128.0 |
| Factor VII (%) | |||||
| Male | 101.8 (25.0)[ | 46.0–128.0 | 78.3–160.4 | 39.0 | 159.0 |
| Female | 82.8 (21.3); 68.0–96.0 | 33.0–903.0 | 61.0–131.0 | 25.0 | 149.0 |
| Factor VIII (%) | |||||
| Male | 95.5 (37.3)[ | 0.01–89.08 | 116.8–239.1 | 4.0 | 181.0 |
| Female | 87.0 (35.2); 33.0–170.8 | 0.01–90.80 | 113.0–228.6 | 21.0 | 183.0 |
| Factor IX (%) | |||||
| Male | 135.0 (24.0)[ | 78.7–157.3 | 106.5–185.1 | 65.0 | 193.0 |
| Female | 106.4 (27.0); 87.7–124.0 | 43.5–132.0 | 79.8–168.2 | 47.0 | 181.0 |
| Factor X (%) | |||||
| Male | 95.2 (15.4)[ | 58.7–109.3 | 81.7–132.3 | 57.0 | 135.0 |
| Female | 83.2 (15.1); 72.0–94.0 | 47.1–96.8 | 69.1–118.8 | 48.0 | 126.0 |
| Factor Xl (%) | |||||
| Male | 108.5 (19.0)[ | 44.3–106.7 | 119.0–132.3 | 63.0 | 156.0 |
| Female | 100.7 (18.5); 63.0–143.0 | 32.7–93.3 | 112.7–173.3 | 59.0 | 156.0 |
| Factor XII (%) | |||||
| Male | 128.1 (34.7)[ | 10.1–124.0 | 144.6–258.6 | 60.0 | 210.0 |
| Female | 103.9 (32.3); 52.2–176.9 | 0.01–105.21 | 123.9–229.9 | 26.0 | 203.0 |
| Factor XIII (%) | |||||
| Male | 128.1 (34.2); 66.6–200.0 | 10.5–122.7–143.9 | 143.9–256.1 | 51.0 | 200.0 |
| Female | 123.3 (34.0); 68.0–200.0 | 12.1–123.8 | 144.1–255.8 | 64.0 | 200.0 |
| Von Willebrand Factor (%) | |||||
| Male | 82.4 (29.7); 58.7–104.3 | 10.0–107.5 | 55.6–153.0 | 38.0 | 151.0 |
| Female | 87.3 (9.2); 78.0–5.2 | 62.8–93.2 | 80.1–110.4 | 73.0 | 101.0 |
| Protein S (%) | |||||
| Male | 95.3 (27.3); 75.9–117.3 | 31.0–120.7 | 72.5–162.2 | 42.7 | 150.0 |
| Female | 88.1 (27.3); 73.2–112.0 | 29.8–116.7 | 68.6–155.4 | 48.4 | 150.0 |
| Protein C (%) | |||||
| Male | 83.6 (20.6); 70.0–98.0 | 36.2–103.7 | 64.2–131.7 | 42.6 | 136.1 |
| Female | 85.1 (22.2); 69.5 (98.8) | 33.0–106.0 | 62.3–135.3 | 31.6 | 143.4 |
| Plasminogen (%) | |||||
| Male | 92.5 (14.5)[ | 58.0–105.4 | 79.5–127.0 | 69.0 | 122.0 |
| Female | 106.6 (8.9); 102.2–114.0 | 87.7–116.8 | 99.4–128.6 | 91.0 | 114.0 |
Significant difference in values between males and females (P<.001) within age groups studied.
Significant difference in values between males and females (P<.05) (student's t-test or Mann-whitney were appropriate).
Hematinic normal reference values in male and female Saudi adults.
| Parameter | Mean (SD) with reference range | Lower limit (90% Cl) | Upper limit (90% Cl) | Minimum | Maximum |
|---|---|---|---|---|---|
| Serum iron (umol/L) | |||||
| Male | 15.7 (5.6)[ | 3.5–21.9 | 10.4–28.8 | 0.3 | 31.1 |
| Female | 16.0 (5.8); 12.5–20.5 | 2.9–22.0 | 10.9–30.0 | 0.9 | 29.8 |
| Serum ferritin (ug/L) | |||||
| Male | 70.6 (61.4)[ | 0.01–115.31 | 137.3–338.7 | 6.3 | 269.0 |
| Female | 43.7 (52.5); 14.2–244.8 | 0.01–100.18 | 158.7–330.8 | 7.8 | 271.0 |
| Serum vitamin B12 (pmol/L) | |||||
| Male | 264.8 (76.7); 266.5–83.6 | 29.2–280.6 | 323.7–575.1 | 149.0 | 496.0 |
| Female | 266.5 (83.6); 147.0–477.0 | 9.9–284.1 | 339.9–614.1 | 146.0 | 480.0 |
| Serum folate (nmol/L) | |||||
| Male | 24.0 (10.7); 6.3–45.5 | 0.01–23.84 | 27.9–63.0 | 5.9 | 45.7 |
| Female | 21.1 (8.3); 6.6–40.8 | 0.01–20.13 | 27.2–54.3 | 6.6 | 40.8 |
Significant difference in values between males and females (P<.001) within age groups.